Indian Journal of Pharmacology Home 

CORRESPONDENCE
[Download PDF]
Year : 2009  |  Volume : 41  |  Issue : 6  |  Page : 289-

Authors' reply

Kavitha S Nair, Kirti V Patel, Tejal R Gandhi 
 Department of Pharmacology, Anand Pharmacy College, Opp. Town Hall, Anand-388001, Gujarat, India

Correspondence Address:
Kavitha S Nair
Department of Pharmacology, Anand Pharmacy College, Opp. Town Hall, Anand-388001, Gujarat
India




How to cite this article:
Nair KS, Patel KV, Gandhi TR. Authors' reply.Indian J Pharmacol 2009;41:289-289


How to cite this URL:
Nair KS, Patel KV, Gandhi TR. Authors' reply. Indian J Pharmacol [serial online] 2009 [cited 2019 Oct 20 ];41:289-289
Available from: http://www.ijp-online.com/text.asp?2009/41/6/289/59932


Full Text

Sir,



It appears from the above discussion that the modulatory role of cytochromes on pioglitazone is doubtful, but numerous evidences has accumulated after the above-cited references that have supported the role of pioglitazone as cytochrome p450 enzyme inducer (although weak). [1],[2]The benefits of ANOVA and post hoc Tuckey can be considered to be equivalent to Chi-square test.

References

1Sahi J, Black CB, Hamilton GA, Zheng X, Jolley S, Rose KA, et al. Comparative effects of thiazolidinediones on In Vitro P450 enzyme Induction And Inhibition. Drug Metab Dispos 2003;31:439-46.
2Ripp SL, Mills JB, Fahmi OA, Trevena KA, Liras JL, Maurer TS, et al. Use of Immortalized Human Hepatocytes to Predict the Magnitude of Clinical Drug-Drug interactions caused by CYP3A4 induction. Drug Metab Dispos 2006;34:1742-8.